Issue 44 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

20

No.

44

November 18, 1994Nov 18, 1994

Free

DOWNLOAD THE PDF

Republican Congress To Shift Priorities, But Cancer May Get New Opportunities

In Brief: Ortho Biotec gives $1 Million To Fund Fatigue Initiative; Lippman, Pike Honored

NCI Won’t Recognize Wolmark Wile NSABP is Plaintiff In Suit

DCE Advisors Okay Contract Recompetitions For Epidemiology

Chemical Carcinogenesis

FDA Rile Changes Reporting Requirements for Adverse Events

Recent Issues

Volume 52 | Issue 15 - April 17, 2026

Volume 52 | Issue 14 - April 10, 2026

Volume 52 | Issue 13 - April 03, 2026

Volume 52 | Issue 12 - March 27, 2026

Volume 52 | Issue 11 - March 20, 2026

Volume 52 | Issue 10 - March 13, 2026